Catalyst Pharmaceuticals ... (CPRX)

AI Score

Unlock

24.26

-0.43 (-1.74%)

At close: Mar 31, 2025, 3:59 PM

23.85

-1.69%

After-hours: Mar 31, 2025, 05:49 PM EDT

Catalyst Pharmaceuticals Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02
Revenue	491.73M	398.2M	214.2M	140.83M	119.07M	102.31M	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	488.96K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	68.84M	84.53M	34.39M	21.88M	17.04M	14.76M	19.92M	45.69K	43.41K	34.47K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	422.89M	313.67M	179.81M	118.95M	102.03M	87.55M	-19.42M	-45.69K	-43.41K	-34.47K	n/a	n/a	n/a	n/a	488.96K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	195.12M	86.81M	101.84M	52.38M	41.3M	31.82M	-35.3M	-18.68M	-19.28M	-20.4M	-14.59M	-10.31M	-5.22M	-6.08M	-4.02M	-7.28M	-10.89M	-5.03M	-2.9M	-1.82M	-542.96K	-428.62K	-255.94K
Interest Income	n/a	n/a	n/a	282K	587K	1.59M	1.29M	454.16K	321.61K	100.39K	76.23K	47.42K	14.98K	10.98K	17.86K	33.47K	329.35K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	216.26M	94.51M	104.72M	52.67M	41.89M	33.41M	-34M	-18.41M	-18.07M	-20.23M	-15.51M	-12.15M	-4.08M	-6.39M	-4.01M	-7.24M	-10.56M	-4.14M	-2.73M	-1.81M	-539.82K	n/a	-255.94K
Net Income	163.89M	71.41M	83.08M	39.48M	74.98M	31.88M	-34M	-18.41M	-18.07M	-20.23M	-15.51M	-12.15M	-4.08M	-6.39M	-4.01M	-7.24M	-10.56M	-4.14M	-2.73M	-1.81M	-539.82K	-428.62K	-255.94K
Selling & General & Admin	177.74M	133.71M	58.18M	49.63M	44.23M	36.88M	15.88M	7.3M	7.91M	8.6M	4.47M	2.21M	2.56M	2.7M	2.21M	2.18M	2.18M	2.04M	1.91M	359.28K	164.7K	n/a	n/a
Research & Development	12.65M	93.15M	19.79M	16.94M	16.5M	18.84M	19.92M	11.38M	11.37M	11.8M	10.12M	8.1M	2.66M	3.38M	2.31M	5.1M	8.71M	2.99M	989.14K	1.46M	378.25K	n/a	137.68K
Other Expenses	37.38M	n/a	2.88M	282K	586.9K	1.59M	1.29M	454.16K	321.61K	100.39K	76.23K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-428.62K	118.27K
Operating Expenses	227.76M	259.43M	77.97M	66.56M	60.73M	55.72M	35.8M	18.68M	19.28M	20.4M	14.59M	10.31M	5.22M	6.08M	4.51M	7.28M	10.89M	5.03M	2.9M	1.82M	542.96K	-428.62K	255.94K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	1.29M	454.16K	321.61K	100.39K	76.23K	47.42K	14.98K	10.98K	17.86K	33.47K	329.35K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	111.34M	86.69M	29.47M	26.15M	23.57M	3.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	296.61M	311.39M	112.36M	88.45M	77.77M	70.48M	35.8M	18.68M	19.28M	20.4M	14.59M	10.31M	5.22M	6.08M	4.51M	7.28M	10.89M	5.03M	2.9M	1.82M	542.96K	-428.62K	255.94K
Income Tax	52.37M	23.1M	21.64M	13.19M	-33.09M	1.53M	2.58M	141.22K	-929.54K	-99.47K	993.87K	1.84M	-1.16M	308.92K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	428.62K	n/a
Shares Outstanding (Basic)	118.46M	106.28M	103.37M	103.38M	103.51M	102.94M	102.63M	85.8M	82.88M	80.86M	64.14M	45.45M	30.03M	21.73M	18.58M	15.07M	13.01M	12.53M	7.69M	6.2M	2.92M	2.92M	2.36M
Shares Outstanding (Diluted)	124.94M	113.75M	111.38M	107.8M	106.24M	106.02M	102.63M	85.8M	82.88M	80.86M	64.14M	45.45M	30.03M	21.73M	18.58M	15.07M	13.01M	12.53M	7.69M	6.2M	2.92M	2.92M	2.36M
EPS (Basic)	1.38	0.67	0.80	0.38	0.72	0.31	-0.33	-0.21	-0.22	-0.25	-0.24	-0.27	-0.14	-0.29	-0.22	-0.48	-0.81	-0.33	-0.36	-0.29	-0.18	-0.15	-0.11
EPS (Diluted)	1.31	0.63	0.75	0.37	0.71	0.30	-0.33	-0.21	-0.22	-0.25	-0.24	-0.27	-0.14	-0.29	-0.22	-0.48	-0.81	-0.33	-0.36	-0.29	-0.18	-0.15	-0.11
EBITDA	195.12M	119.69M	101.84M	52.38M	41.3M	31.82M	-35.26M	-18.49M	-18.03M	-20.46M	-13.57M	-8.4M	-6.35M	-6.35M	-4M	-7.21M	-10.53M	-5.01M	-2.72M	-1.82M	-542.59K	-428.62K	-255.94K
Depreciation & Amortization	n/a	32.88M	1.49M	484K	885.32K	297.73K	37.98K	45.69K	43.41K	34.47K	26.57K	22.48K	10.89K	42.84K	25.74K	30.23K	32.76K	15.76K	4.93K	1.37K	366.00	n/a	n/a